Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway
Dandan Liu, Hua Xu, Chaoyang Zhang, Hai Xie, Qian Yang, Weiye Li, Haibin Tian, Lixia Lü, Jingying Xu, Guoxu Xu, Guoxu Xu, Kun Liu, Xiaodong Sun, Guo‐Tong Xu, Guo‐Tong Xu, Jingfa Zhang
Topics & Concepts
ErythropoietinVE-cadherinVascular endothelial growth factorBlood–retinal barrierUmbilical veinEndocrinologyInternalizationFluorescein isothiocyanateErythropoietin receptorInternal medicineMedicineDiabetic retinopathyChemistryReceptorEndothelial stem cellDiabetes mellitusIn vitroBiochemistryVEGF receptorsPhysicsQuantum mechanicsFluorescenceRetinal Diseases and TreatmentsErythropoietin and Anemia TreatmentBarrier Structure and Function Studies